WHO ICTRP trial
Elective induction of labor at 39 weeks versus expectant management in low risk…
CTRI/2021/10/037487 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2021/10/037487 |
|---|---|
| Public title | Elective induction of labor at 39 weeks versus expectant management in low risk nulliparous women |
| Scientific title | Elective induction of labor at 39 weeks versus expectant management in low risk nulliparous women : a pilot randomized controlled trial - EIOL-NUL |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2/ Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: O610- Failed medical induction of labor |
| Interventions | Intervention1: Induction Protocol: Dose: dinoprostone gel 0.5 mg (maximum three doses) Frequency : 6 hourly Route : intracervical Duration : 18-24 hours Induction protocol: cervical priming will be done by dinoprostone gel 0.5mg… |
| Registration date | Oct 22, 2021 |
| Target size | 60 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: